Debut Plus

₹24.55

▼ -0.9 -3.54%

As of 23 Oct 2026 · delayed

NSE Listed · Pharmaceuticals

Medicamen Organics Ltd. (MEDIORG)

Volume: 2,000Avg Vol 1W: 3,200Avg Vol 1M: 9,27352W Range:₹19.1₹38
Key Ratios
Checked 1h ago
Market Cap₹119 Cr
Current Price₹24.55
Previous Close₹25.45
High / Low (52w)₹38 / ₹19.1
Volume2,000
Avg Vol (1W)3,200
Avg Vol (1M)9,273
Stock P/E6.27
Book Value₹23.68
Dividend Yield—
ROE—
ROA—
Revenue (TTM)—
Revenue Growth51.11%
Profit Margin—
Total Debt₹15,75,000 Cr
Shares Outstanding—
Face Value—
EPS (TTM)₹-2.5
P/B1.04
Debt / Equity0.45
50 DMA₹24.82
200 DMA₹24.73
Day change-3.54%
Price Chart
₹24.55▼ 33.11% · 1Y
₹38₹191.3L
2025-10-27
2026-10-23

20-day avg volume: 8K shares

Pros
  • Company is almost debt-free.
Cons
  • Revenue fell 41% YoY.
  • Company is loss-making at the latest annual result.
Profit & Loss (Annual)
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue₹32 Cr₹25 Cr₹21 Cr₹23 Cr₹25 Cr₹38 Cr₹23 Cr
EBITDA₹1 Cr₹1 Cr₹1 Cr₹2 Cr₹4 Cr₹6 Cr₹-5 Cr
Net Profit₹0 Cr₹0 Cr₹0 Cr₹1 Cr₹3 Cr₹4 Cr₹-4 Cr
EPS0.170.50.151.623.473.66-3.41
Balance Sheet
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹26 Cr₹26 Cr₹27 Cr₹33 Cr₹38 Cr₹59 Cr₹52 Cr
Total Liabilities₹19 Cr₹19 Cr₹20 Cr₹24 Cr₹23 Cr₹29 Cr₹23 Cr
Equity₹7 Cr₹7 Cr₹8 Cr₹9 Cr₹15 Cr₹30 Cr₹29 Cr
Total Debt₹0 Cr₹1 Cr₹1 Cr₹0 Cr———
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹-1 Cr₹0 Cr₹-1 Cr₹-3 Cr₹-4 Cr₹-4 Cr
Investing₹0 Cr₹-1 Cr₹0 Cr₹0 Cr₹-2 Cr₹-2 Cr
Financing₹1 Cr₹0 Cr₹1 Cr₹4 Cr₹10 Cr₹3 Cr
Free Cash Flow₹-1 Cr₹0 Cr₹-1 Cr₹-3 Cr₹-4 Cr₹-4 Cr
Shareholding
Promoter 54.89% Institutions 0.05% Public 45.05%
Efficiency & Working Capital
ROCE16.9%
Interest Coverage-5.3
Dividend Payout—
Debtor Days300 d
Inventory Days170 d
Payable Days90 d
Cash Conversion Cycle380 d
Working Capital Days470 d
Shareholding Details

As of 2026-09-30

Promoter54.9%
FII0.1%
DII0%
Institutions0.1%
Public45.1%
Promoter Pledge0%
No. of Shareholders445
Shareholding Pattern

Quarterly — figures in %. Latest 11 quarters.

PeriodFeb 2024Feb 2024Jun 2024Sept 2024Mar 2025Sept 2025Jan 2026Jan 2026Mar 2026Jun 2026Sept 2026
Promoters81.2%81.2%59.7%59.7%59.7%59.7%61.3%61.3%59.7%54.9%54.9%
FIIs0%0%2.2%0.1%0.1%0%0.1%0.1%0.1%0.1%0.1%
DIIs18.8%0%0.3%0.1%0.1%0%3.6%3.6%1.6%0%0%
Public0%18.8%37.8%40.1%40.1%40.3%35.1%35.1%38.6%45.1%45.1%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders3434471379460507515515540508445
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Bal Kishan GuptaShareholding of Promoter and Promoter Group48.9%72,82,845
Pradeep Kumar JainPublic Shareholding13.9%20,72,000
Shivani ChopraPublic Shareholding4%6,00,000
Ashutosh GuptaShareholding of Promoter and Promoter Group4%5,91,400
Abhishek KaushikPublic Shareholding2.1%3,16,000
Ritu Gupta .Shareholding of Promoter and Promoter Group1.9%2,86,500
Pawan Kumar GuptaPublic Shareholding1%1,52,000
Ishaan GuptaShareholding of Promoter and Promoter Group0.1%7,050
Bkgupta & Sons .Shareholding of Promoter and Promoter Group0%300
Board of Directors
NameDesignationYear
B K GuptaChairman / Executive Director / Managing Director2025
Ashutosh GuptaE D & Wholetime Director2025
Brijesh Kumar ChaubeyExecutive Director2025
Sneh GaurNon-Exec & Non-Independent Dir2025
Rakesh KumarIndependent Non Exe. Director2025
Rajinder Kumar GuptaIndependent Non Exe. Director2025
Sachin GuptaIndependent Non Exe. Director2025
Varsha BansalCompany Sec. & Compli. Officer2025
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹10141212
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202610015017
2026100809
2026100708
Company Information
Incorporated1995
ChairmanB K Gupta
AuditorN C Raj & Associates
Investor Email[email protected]
🌐 www.medicamenorganics.com ↗

📍 10 Community Centre No 2, Ashok Vihar Phase II, New Delhi, Delhi, 110052

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search